LAVA Therapeutics (NASDAQ:LVTX) Sees Large Decline in Short Interest
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) was the recipient of a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 21,800 shares, a decline of 25.3% from the October 15th total of 29,200 shares. Approximately 0.2% of the shares of the company are sold […]
United States Therapeutics Company Profile Bruce Co America Corp Renaissance Technologies Financial Services Group Inc
Source: modernreaders.com